INTRODUCTION
Achieving and maintaining self-tolerance are of central importance for an effective immune system. In the case of T-cell tolerance, this is generally accomplished by elimination of self-reactive cells either during development in the thymus (Kappler et al., 1987; MacDonald et al., 1988) or after encountering self-antigen in the periphery (Jones et al., 1990; Webb et al., 1990; Kawabe and Ochi, 1991; Rocha et al., 1992) ; however, some potentially autoreactive cells are not physically deleted but are rendered unresponsive to self-antigens (Schwartz, 1989; Blackman et al., 1990; Ramsdell and Fowlkes, 1990) . Such cells can be permanently incapacitated in their ability to respond to antigen or can be restimulated in vitro or in vivo by exposure to high levels of antigen and/or to different cytokines. The unresponsiveness maintained in some nondeletional tolerant states has been attributed to the downregulation of the reactive TCR Corresponding author. National Institute for Medical Research, The Ridgeway, London NW7 1AA, UK. (Sch6nrich et al., 1991) and/or the coreceptor CD4 or CD8 (Rocha et al., 1992) . In addition, other factors such as transcription levels of certain genes or efficiency in costimulation and signal transduction may be affected in this process (Mueller et al., 1989) .
It is important to understand the mechanisms underlying the induction and maintenance of the tolerant state of T cells in order to be able to intervene in cases where their untimely activation causes autoimmune disease. To study the phenomenon in more controlled situations, several groups have followed a strategy that attempts to keep one or more of the participating elements constant. Such central candidates are the T-cell receptor (TCR) and the cognate antigen: Thus, T-cell-receptor (TCR) transgenic mice have been crossed to mice that express the cognate antigen.
We have generated a TCR transgenic mouse that bears on most of its T cells a TCR (F5) that recognizes a nonamer peptide (366) (367) (368) (369) (370) (371) (372) (373) (374) NP peptide) from the influenza virus (A/NT/60/68) nucleoprotein in the context of class I MHC (Db) (Townsend et al., 1986; Mamalaki et al., 1993a) . Most T cells in 300 C. MAMALAKI et al. F5 TCR transgenic mice are CD8 cytotoxic cells and can respond to the cognate antigen (peptide or viral protein) both in vivo and in vitro (Mamalaki et al., 1992 (Mamalaki et al., , 1993a . The utilization by the receptor of the V131 member of the -chain gene family also confers reactivity to endogenous superantigens (Mtv 8, 9, and 11) when presented by H-2E class II MHC molecules (Dyson et al., 1991) . In the past, we have reported the creation of a tolerant state in F5 TCR transgenic mice when they are crossed with H-2E mice carrying Mtv8 and Mtv9 (Mamalaki et al., 1993a) . In that case, we demonstrated that hybrids of F5 mice bred with (Mamalaki et al., 1993a (Townsend et al., 1986) . The H-2K b promoter was joined to the deleted NP gene, and an intron and poly-A signal from the SV40 T antigen were added to generate the H2NP construct (Fig. 1) . In transgenic mice expressing this construct, the foreign antigen becomes a self-protein expressed in most cells of the body.
The construct was injected into fertilized mouse (C57B1/10) eggs and several transgenic lines were generated: four of these were used in this study (H2NP10, H2NP22, H2NP40, and H2NP47 (Fig. 3C ). The findings in the thymus were reflected in the periphery of F5/H2NP double-transgenic mice. Lymph nodes of the mice described before were stained for CD4, CD8, and VI1. Figure 4A shows that the proportion of CD8 cells was drastically reduced from an average of 53-68% in F5 Because allelic exclusion in TCR mice is not complete, particularly at the 0-chain gene locus (Mamalaki et al., 1993b) , the presence of doublepositive CD4/8 thymocytes and CD8 VI" peripheral cells in F5/NP doubl.e-transgenic mice could be explained by the fact that they may express endogenous 0 and receptors, which allow them to be positive selected.
To test this possibility, we generated F5/NP double-transgenic mice unable to rearrange endogenous TCR genes. Thus, F5/H2NP mice were bred with Recombination Activating Gene-l-deficient mice (RAG-I-/-) F5/H2NP40 4 dp 4,557 4,311 F5/H2NP40 4 dp (Kappler et al., 1987; MacDonald et al., 1988) . Mice transgenic for antigen-specific T-cell receptors have extended these observations (Kisielow et al., 1988; Berg et al., 1989; Pircher et al., 1989; Hhmmerling et al., 1991; Morahan et al., 1991; Sch6nrich et al., 1991; Auphan et al., 1992; Husbands et al., 1992; Geiger et al., 1993; Sch6nrich et al., 1993; Oehen et al., 1994; Sponaas et al., 1994) .
In this paper, we studied the forms of negative (Gay et al., 1993; Tiegs et al., 1993) .
In F5/RAG-I-/-mice, we still found CD8 mature T cells that are tolerant due to F5 TCR and CD8 coreceptor downregulation. We found a correlation between the extent of F5 TCR downregulation and the apparent levels of NP antigen expression on antigen-presenting cells in H2NP mice. That is, the more antigen, the lower the receptor. Therefore An interesting observation concerns the reactivity of F5 CD8 T cells present in H2 bk mice compared to those found in F5/H2NP double-transgenic mice. In both cases, CD8 T cells in peripheral lymphoid organs have low levels of TCR and are present in lower numbers. However, as we reported before (Mamalaki et al., 1993a ; and this study), F5 CD8 cells from F5/H2 bk mice that are presumably tolerant to endogenous Mtv antigens still react to cognate antigen (Table 1) . On the other hand, F5 CD8 T cells from F5/H2NP mice only respond to cognate peptide by downregulating their TCR even further. This is a similar situation reported with mice transgenic for a TCR specific for LCMV and an endogenous superantigen (Pircher et al., 1989; Kawai and Ohashi, 1995) .
We conclude from these findings that in F5TCR mice, negative selection of self-reactive thymocytes, whether to H-2E/Mtv (MHC Class II restricted reactivity) or to nucleoprotein (MHC Class I reactivity), occurs at the transition from CD4+8+TCR to CD4/8+TCRhi. It is unclear at the moment whether this involves physical elimination of developing thymocytes at the point of upregulation of the receptor or arrest of these thymocytes at the TCR 1 stage due to the presence of the antigen (Takahama et al., 1992; Swat et al., 1994) .
The picture observed in F5/NP double-transgenic mice strongly resembles that developing in F5 single-transgenic mice treated with cognate peptide long term. In such long-term peptide-treated mice, the thymus contains CD4/8 cells bearing low levels of TCR and the peripheral lymphoid organs contain very few CD8 T cells with low levels of transgenic TCR (Mamalaki et al., 1993b) . Thus, chronic exposure of mice to cognate antigen leads to a situation similar to tolerance toward self-antigens.
Additional exposure of tolerant T cells to high levels of antigen in other experimental models has led to further tolerization of these cells by downmodulation of the TCR and/or the coreceptor (Himmerling et al., 1991) . Further antigenic exposure of T cells from F5/NP double-transgenic mice did not enhance their tolerization, judging from the levels of TCR and coreceptor: These remained unchanged after treatment with the antigenic peptide.
When we repeated this experiment using RAG-1-/-mice, we saw that the few CD8 F5TCR 1 cells present in the periphery did downregulate their receptor and coreceptor even further upon exposure to higher levels of antigen given as exogenously administered peptide. This is in agreement with evidence from an alloreactive transgenic TCR model (Himmerling et al., 1991) , and confirms that whereas the tolerance induced in double-transgenic mice is sufficient for the levels of nucleoprotein transgene expressed, however, when higher levels of antigen are introduced, the cells downregulate their TCR even fur- In a study by Oehen et al. (1994) Mice were generated and maintained in a conventional colony free of pathogens at the National Institute for Medical Research in London, F5 TCR and H2NP transgenic mice were generated as described previously (Lang et al., 1988; Mamalaki et al., 1993a) using inbred C57B1/10 mice. Influenza nucleoprotein peptide (366) (367) (368) (369) (370) (371) (372) (373) (374) Townsend et al., 1985) that contains sequences coding for 0c1, 2, and 328-498 of the nucleoprotein from the influenza virus (the deletion removes amino acids 3-327). Third, the resulting plasmid was cleaved at the EcoRI site of the Bluescript polylinker and the SmaI site described in the first cloning step and an EcoRI-NruI fragment from the H2-K b promoter was inserted (Weiss et al., 1983 Antigen-presenting cells were prepared by a modified protocol published previously (Tanaka, 1993 
